Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial

NCT03472495 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03472495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03472495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
Lead sponsor
Virginia Commonwealth University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2018
Completion date
March 21, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation and flutter